The microbial community of patients is always influenced by various environmental and clinical factors, such as demography, diet, complications, etc. Therefore, we chose the NOD mice, a model for autoimmune diseases (Aoki et al., 2005; Kim et al., 2020), to better evaluate the influence of IL-2 treatment on gut microbiota. This evidence concerns the gene IL2 and autoimmune disease.